Monographie - Gemcitabine hydrochloride

Laatste update :
03/05/2024

Gemcitabine hydrochloride

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Accogem	Mexico
Antoril	Argentinië
Axigem	Duitsland
Bendacitabin	Duitsland
Binoptos	Mexico
Celzar	Peru
Dercin	Roemenië
Dhacibine	Maleisië
Emcitab	Colombia
Eriogem	Argentinië, Ecuador
Fotinex	Argentinië, Peru
Gebina	Argentinië
Gebitan	Colombia
Gembio	Argentinië, Chili, Ecuador
Gemcimira	Chili, Peru
Gemcit	Portugal
Gemcitabin	Duitsland
Gemcitac	Chili
Gemko	Turkije
Gemsibin	Turkije
Gemsol	Oostenrijk
Gemtero	Chili, Peru
Gemzar	Australië, België, Brazilië, Canada, Chili, Colombia, Denemarken, Duitsland, Ecuador, Egypte, Finland, Frankrijk, Griekenland, Groot Britannië, Hongarije, Ierland, IJsland, Iran, Italië, Kroatië, Luxemburg, Maleisië, Marokko, Mexico, Nederland, Nieuw Zeeland, Noorwegen, Oostenrijk, Polen, Portugal, Roemenië, Slovenië, Spanje, Thailand, Tunisie, Turkije, USA, Venezuela, Verenigde Arabische Emiraten, Zuid-Afrika, Zweden, Zwitserland
Gentabin	Colombia
Haxanit	Argentinië, Peru
Lenfotabin	Mexico

Literatuur : Gemcitabine hydrochloride

	Type	Publicatie
1422	Artikel	Xu QA, Zhang Y, Trissel LA. Physical and chemical stability of gemcitabine hydrochloride solutions. J Am Pharm Assoc 1999 ; 39: 509-513.
1423	Artikel	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1501	Artikel	Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M. Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Int J Pharm 1999 ; 185: 113-121.
1520	Fabrikant	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1611	Artikel	Chalmers JR, Bobek MB, Militello MA. Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs. Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625	Artikel	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1662	Artikel	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1663	Artikel	Ponton JL, Munoz C, Rey M, Val M. The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection. EJHP 2002 ; 1: 23-25.
1925	Artikel	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1953	Artikel	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Artikel	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009	Artikel	Trissel LA, Zhang Y. Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262	Artikel	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344	Fabrikant	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution. Ebewe Pharma 2009
3262	Artikel	Manners S, Galettis P, de Souza P. Conditions causing gemcitabine crystallization. J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496	Fabrikant	Gemcitabin Actavis solution - Stability Study Actavis 2009
3670	Artikel	Sewell G, Massimini M. Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system. EJOP 2014 ; 8, 3: 26-30.
4310	Artikel	Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M. Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736	Artikel	Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023

Mentions Légales